Thonzylamine
 | |
| Clinical data | |
|---|---|
| Synonyms | Neohetramine |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| ECHA InfoCard | 100.001.913 |
| Chemical and physical data | |
| Formula | C16H22N4O |
| Molar mass | 286.372 g/mol |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Thonzylamine (or neohetramine)[1] is an antihistamine and anticholinergic used as an antipruritic.
Synthesis
Thonzylamine synthesis: H. L. Friedman and A, V. Tolstouhov, U.S. Patent 2,465,865 (1949).
See also
References
| Antihistamines for topical use | |
|---|---|
| Anesthetics for topical use | |
| Others |
|
Decongestants and other nasal preparations (R01) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Topical |
| ||||||||
| Systemic use: Sympathomimetics | |||||||||
| Aminoalkyl ethers |
|
|---|---|
| Substituted alkylamines | |
| Substituted ethylenediamines |
|
| Phenothiazine derivatives | |
| Piperazine derivatives | |
| Others for systemic use |
|
| For topical use | |
| H1 |
|
|---|---|
| H2 |
|
| H3 |
|
| H4 |
|
See also: Receptor/signaling modulators • Monoamine metabolism modulators • Monoamine reuptake and release modulators | |
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.